Introducing the AJCC 8th Edition Editorial Board and Expert Panel Leaders
The AJCC is pleased to introduce the thought leaders of the AJCC Cancer Staging System, 8th Edition.
Led by Mahul B. Amin, MD, FCAP, the 15 member Editorial Board features representatives from each cancer specialty, and leaders of internal development “cores” – a new concept introduced by Dr. Amin. These cores are tasked with harmonizing specific areas of staging system development, including:
Precision Medicine Core – focused on integrating non-anatomic prognostic factors into the staging system
Evidence Based Medicine and Statistics Core – focused on developing levels of evidence for changes and updates to the staging system
Content Harmonization Core – focused on harmonizing terms and concepts used in the staging system
Data Collection Core – focused on collaboration with the surveillance community to assure medical record access to and quality of 8th edition data elements
Professional Organization and Corporate Relationship Core – manages grants and contributions for development of the AJCC Cancer Staging System
Administrative Core – oversees the development process of the staging system
The 8th Edition will be authored by a team of 18 Expert Panels, each steered by a Chair and Vice Chair selected by the Editorial Board. The composition of each expert panel strives to collaboratively harness the collective intelligence of the thought leaders for each disease site. The membership represents diversity of thought and specialty; each panel's Chair and Vice Chair come from different organizations and represent different specialties.
The full roster of Editorial Board members and Expert Panel leaders can be found here.
Formation of the full expert panels is underway and is expected to be completed by year-end.
The 8th edition will be effective for all cancer cases recorded on or after January 1, 2017. Visit our website for all 8th Edition Updates. We look forward to a collaborative development process!
8th Edition Publication Date Announced
The AJCC Executive Committee recently announced a mid-2016 publication date for the 8th edition AJCC Cancer Staging System during its 2013 Annual Meeting held this September in Chicago. The 8th edition will be effective for all cancer cases recorded on or after January 1, 2017. Key activities prior to the 2016 publication date include:
careful analysis of data collected since the 7th Edition's release in 2010;
thoughtful validation of prognostic and predictive factors for incorporation in the staging system; and
continued deep collaboration with standard setters and key partners to anticipate, communicate, and help incorporate staging system changes to the cancer care and surveillance community.
Keep checking here for more 8th Edition updates. We look forward to an exciting development process!
Editor-in-Chief Announced for AJCC Cancer Staging Manual, 8th Edition
Dr. Amin brings multidisciplinary approach and molecular-based medical perspective on cancer staging to national editorial position
Mahul B. Amin, MD, FCAP, has been named Editor-in-Chief of the upcoming eighth edition of the AJCC Cancer Staging Manual. Dr. Amin is currently Chairman and Professor of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, Los Angeles.
The eighth edition of the Cancer Staging Manual, which is expected to be published in late 2016 for patients diagnosed with cancer after January 2017, will incorporate advances made in cancer research, staging, diagnosis, and treatment since the seventh edition was published in October 2009.
The editorial development process will involve a collaboration of approximately 500 cancer experts from around the world, and will cover more than 60 primary disease sites.